山东大学学报 (医学版) ›› 2025, Vol. 63 ›› Issue (1): 35-42.doi: 10.6040/j.issn.1671-7554.0.2024.0570
• 临床研究 • 上一篇
张洁1,张芳芳1,王靖楠2,李泽宇1,宋颖1,李娜1
ZHANG Jie1, ZHANG Fangfang1, WANG Jingnan2, LI Zeyu1, SONG Ying1, LI Na1
摘要: 目的 探究circ_0000144在乳腺癌组织中的表达及其对乳腺癌细胞增殖、凋亡、迁移和侵袭能力的影响。 方法 通过实时荧光定量PCR(quantitative real-time polymerase chain reaction, RT-qPCR)实验检测49例乳腺癌及配对癌旁正常乳腺组织标本中的circ_0000144表达水平,并分析circ_0000144的表达水平与乳腺癌患者临床病理特征的关系;以正常乳腺上皮细胞MCF-10A为对照,RT-qPCR法检测乳腺癌细胞系(T47D、MCF-7、MDA-MB-231)中circ_0000144表达;以MCF-7细胞为研究对象,将转染si-circ_0000144组设为实验组(si-circ_0000144组),将转染si-NC组设为生理盐水对照组(si-NC组),同时设置空白对照组(Control组),细胞不进行任何转染操作,用常规培养基进行培养,通过CCK-8、克隆形成实验、流式细胞术、划痕实验、Transwell实验检测乳腺癌细胞中细胞增殖、迁移和侵袭的能力,Western blotting法检测相关蛋白CyclinD1、p21、Bax、Bcl-2、E-cadherin和N-cadherin表达。 结果 与癌旁正常组织比较,乳腺癌组织中circ_0000144表达显著升高(P<0.001),且与TNM分期和淋巴结转移呈密切正相关(P=0.003,P=0.007);与正常乳腺上皮细胞MCF-10A比较,乳腺癌细胞系中circ_0000144表达上调(P<0.001);与Control组或si-NC组比较,si-circ_0000144组增殖、迁移和侵袭能力降低(P均<0.001),凋亡率升高(P均<0.001),CyclinD1、Bcl-2和N-cadherin蛋白表达水平降低(P均<0.001),而p21、Bax和E-cadherin蛋白表达水平升高(P均<0.001)。 结论 circ_0000144在乳腺癌组织及细胞系中呈高表达,下调circ_0000144可阻碍乳腺癌细胞增殖、迁移和侵袭,而促进其凋亡,circ_0000144有望成为治疗乳腺癌的分子靶点。
中图分类号:
[1] Sung H, Ferlay J, Siegel RL, et al. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 dountries[J]. CA Cancer J Clin, 2021, 71(3): 209-249. [2] 董相君, 李娟, 孔雪, 等. 环状 RNA hsa_circ_0008591 对乳腺癌细胞生物学行为的影响[J]. 山东大学学报(医学版), 2023, 61(2): 78-87. DONG Xiangjun, LI Juan, KONG Xue, et al. Effects of circular RNA hsa_circ_0008591 on tumor biological behavior of breast cancer cells[J]. Journal of Shangdong University(Health Sciences), 2023, 61(2): 78-87. [3] Wang SY, Fu SQ, Chen Q, et al. Prognostic role of circular RNAs expression in bladder carcinoma: a meta-analysis[J]. Genet Test Mol Biomarkers, 2020, 24(11): 692-700. [4] Mi LL, Lei LH, Yin XL, et al. Circ_0000144 functions as a miR-623 sponge to enhance gastric cancer progression via up-regulating GPRC5A[J]. Biosci Rep, 2020, 40(8): 1-12. [5] Ji F, Lang C, Gao P, et al Knockdown of Circ_0000144 suppresses cell proliferation, migration and invasion in gastric cancer via sponging MiR-217[J]. J Microbiol Biotechnol, 2021, 31(6): 784-793. [6] Yang B, Wang YW, Zhang K. Interactions between circRNA and protein in breast cancer[J]. Gene, 2024, 895: 148019. doi: 10.1016/j.gene.2023.148019. [7] Kristensen LS, Jakobsen T, Hager H, et al. The emerging roles of circRNAs in cancer and oncology[J]. Nat Rev Clin Oncol, 2022, 19(3): 188-206. [8] Zhang Y, Luo J, Yang W, et al. CircRNAs in colorectal cancer: potential biomarkers and therapeutic targets[J]. Cell Death Dis, 2023, 14(6): 353. doi: 10.1038/s41419-023-05881-2. [9] Li J, Zhang Q, Jiang D, et al. CircRNAs in lung cancer- role and clinical application[J]. Cancer Lett, 2022, 544: 215810. doi: 10.1016/j.canlet.2022.215810. [10] Lu JC, Ma XM, Lin JH, et al. Circ_0020123 increases ZFX expression to facilitate non-small cell lung cancer progression by sponging miR-142-3p[J]. Cancer Manag Res, 2021, 13(5): 1687-1698. [11] Fan YX, Shi HY, Hu YL, et al. Circ_0000144 facilitates the progression of thyroid cancer via the miR-217/AKT3 pathway[J]. J Gene Med, 2020, 22(12): e3269. doi:10.1002/jgm.3269. [12] Wei JM, Wang JM, Gao XB, et al. Identification of differentially expressed circRNAs and a novel hsa_circ_0000144 that promote tumor growth in gastric cancer[J]. Cancer Cell Int, 2019, 19: 268. doi:10.1186/s12935-019-0975-y. [13] Huang WP, Lu YY, Wang F, et al. Downregulation of circular RNA hsa_circ_0000144 inhibits bladder cancer progression via stimulating miR-217 and suppressing RUNX2 expression[J]. Gene, 2018, 678: 337-342. doi:10.1016/j.gene.2018.08.036. [14] 韩森吉, 李媛, 李振, 等. IL-37 通过调控 LINC01554/miR-223-3p 轴抑制卵巢癌细胞增殖、迁移和侵袭[J]. 中国免疫学杂志, 2022, 38(13): 1607-1613. HAN Senji, LI Yuan, LI Zhen, et al. IL-37 inhibits proliferation, migration and invasion of ovarian cancer cells by regulating LINC01554/miR-223-3p axis[J]. Chinese Journal of Immunology, 2022, 38(13): 1607-1613. [15] Benard O, Qian X, Liang HZ, et al. p21CIP1 promotes mammary cancer-initiating cells via activation of Wnt/TCF1/CyclinD1 signaling[J]. Mol Cancer Res, 2019, 17(7): 1571-1581. [16] Dai XL, Guo X, Liu JJ, et al. Circular RNA circGRAMD1B inhibits gastric cancer progression by sponging miR-130a-3p and regulating PTEN and p21 expression[J]. Aging, 2019, 11(21): 9689-9708. [17] Sun D, Wang G, Xiao C, et al. Hsa_circ_001988 attenuates GC progression in vitro and in vivo via sponging miR-197-3p[J]. J Cell Physiol, 2021, 236(1): 612-624. [18] Bi JM, Liu HW, Dong W, et al. Circular RNA circ-ZKSCAN1 inhibits bladder cancer progression through miR-1178-3p/p21 axis and acts as a prognostic factor of recurrence[J]. Mol Cancer, 2019, 18(1): 133. doi:10.1186/s12943-019-1060-9. [19] Jia XB, Zhang Q, Xu L, et al. Lotus leaf flavonoids induce apoptosis of human lung cancer A549 cells through the ROS/p38 MAPK pathway[J]. Biol Res, 2021, 54(1): 7. doi:10.1186/s40659-021-00330-w. [20] 魏闫若雪, 李梓绮, 刘春铖, 等. 结直肠癌中SP1的瘤内异质性表达及其临床意义[J]. 山东大学学报(医学版), 2024, 62(5): 89-94. WEI Yanruoxue, LI Ziqi, LIU Chuncheng, et al. Heterogeneous expression of SP1 in colorectal cancer and its clinical significance[J]. Journal of Shandong University(Health Sciences), 2024, 62(5): 89-94. [21] Si AF, Wang LQ, Miao K, et al. MiR-219 regulates liver cancer stem cell expansion via E-cadherin pathway[J]. Cell Cycle, 2019, 18(24): 3550-3561. [22] Jin JL, Liu H, Jin MS, et al. Silencing of hsa_circ_0101145 reverses the epithelial-mesenchymal transition in hepatocellular carcinoma via regulation of the miR-548c-3p/LAMC2 axis[J]. Aging(Albany NY), 2020, 12(12): 11623-11635. [23] Pei C, Wang H, Shi C, et al. CircRNA hsa_circ_0013958 may contribute to the development of ovarian cancer by affecting epithelial-mesenchymal transition and apoptotic signaling pathways[J]. J Clin Lab Anal, 2020, 34(7): e23292. doi: 10.1002/jcla.23292. [24] Chen WL, Jiang L, Wang JS, et al. Circ-0001801 contributes to cell proliferation, migration, invasion and epithelial to mesenchymal transition(EMT)in glioblastoma by regulating miR-628-5p/HMGB3 axis[J]. Eur Rev Med Pharmacol Sci, 2019, 23(24): 10874-10885. [25] 张艳霞, 闫燕艳, 邓亮, 等. E-钙黏素和N-钙黏素在胃肠道间质瘤中的表达及其临床意义[J]. 山西大同大学学报(自然科学版), 2023, 39(1): 80-83. ZHANG Yanxia, YAN Yanyan, DENG Liang, et al. Expression and clinical significance of E-cadherin and N-cadherin in gastrointestinal stromal tumors[J]. Journal of Shanxi Datong University(Natural Science Edition), 2023, 39(1): 80-83. |
[1] | 张士宝 刘庆勇 阮喜云 陈杰 张建军 李宗武 杨广笑 王全颖. NT4-SAC-HA2-TAT融合基因表达载体的构建及鉴定[J]. 山东大学学报(医学版), 2209, 47(6): 15-19. |
[2] | 王晓磊 张海涛 张辉 郭成浩. 舒血宁注射液对高碘致培养血管内皮细胞损伤的保护作用[J]. 山东大学学报(医学版), 2209, 47(6): 38-. |
[3] | 鹿向东 杨伟 徐广明 曲元明. 脑膜瘤中PPAR-γ的表达及曲格列酮对脑膜瘤培养细胞生长的影响[J]. 山东大学学报(医学版), 2209, 47(6): 65-. |
[4] | 山东省医学会乳腺疾病多学科联合委员会. 乳腺癌多学科协作诊疗山东共识(2024年版)[J]. 山东大学学报 (医学版), 2025, 63(1): 10-16. |
[5] | 程跃启,王斐,于理想,郑超,余之刚. 曲妥珠单抗致HER2阳性乳腺癌患者心脏毒性的研究进展[J]. 山东大学学报 (医学版), 2025, 63(1): 17-24. |
[6] | 王敏,李习平,檀军,邱梅,侯泽宇,田莹,罗鸿莹,范超文,齐玲,俞琦,谢薇. 慢病毒载体介导Gag-Caspase-8诱导三阴性乳腺癌原代细胞凋亡及S期阻滞[J]. 山东大学学报 (医学版), 2025, 63(1): 25-34. |
[7] | 余之刚,郑超. 乳腺癌多学科诊疗的现状、挑战与创新模式[J]. 山东大学学报 (医学版), 2025, 63(1): 1-9. |
[8] | 刘向荣,张新胜,杨荩冉,杨雪艳,刘钊,刘英华. ω-6/ω-3多不饱和脂肪酸比值对不同肿瘤发病风险的系统综述和Meta分析[J]. 山东大学学报 (医学版), 2024, 62(8): 34-48. |
[9] | 杜学识,倪向敏,梁馨予,白倩,朱文艺,王建. 雌马酚对DN的保护作用及潜在靶点[J]. 山东大学学报 (医学版), 2024, 62(8): 49-58. |
[10] | 王静,刘晓菲,曾荣,许长娟,张锦涛,董亮. 基于机器学习算法鉴定哮喘的坏死性凋亡相关生物标志物[J]. 山东大学学报 (医学版), 2024, 62(7): 21-32. |
[11] | 张学宇,张学海,孙文青,刘晗,姜金波,刘寒,李远,陈晓梅. 重症新型冠状病毒肺炎伴侵袭性肺曲霉病及反复致命性消化道出血1例[J]. 山东大学学报 (医学版), 2024, 62(7): 56-61. |
[12] | 姜子晗,芦兴晨,孙露,赵蕙琛,左丹,马小莉,刘元涛,张玉超. NR4A1通过IκBα/NF-κB通路调控过氧化氢诱导人脐静脉内皮细胞凋亡的机制[J]. 山东大学学报 (医学版), 2024, 62(3): 11-19. |
[13] | 曹华琳,贾彦召,曲莉,尹昕. CircFAT1调节miR-296-3p/MAPRE1轴对鼻咽癌细胞增殖、凋亡和放疗敏感性的影响[J]. 山东大学学报 (医学版), 2023, 61(9): 38-46. |
[14] | 高玉杰,龙启福,胡英,许玉珍,王茹,永胜. 生物信息学鉴定低氧诱导小鼠肾脏线粒体损伤的Hub基因及其作用机制[J]. 山东大学学报 (医学版), 2023, 61(9): 57-68. |
[15] | 刘金波,刘凯文,向崇鑫,程雷. 西红花苷对椎间盘退变的保护作用[J]. 山东大学学报 (医学版), 2023, 61(9): 84-93. |
|